Company Management

Kuur Therapeutics

Biotechnology Research 2617 Bissonnet St 8 employees

Employees: 8
Contacts: 2
Emails: 2

kuurtx.com LinkedIn Crunchbase

Kuur Therapeutics Overview

Headquarters: 2617 Bissonnet St
Phone Number: Available in AeroLeads
Website: kuurtx.com
Industry: Biotechnology Research
Employees: 8
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immunotherapy Cancer Oncology T cells TCR CAR CAR-NKT clinical trial NKT Cells celltherapy lifesciences

About Kuur Therapeutics

Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.

Kuur Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Kuur Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Pfukane Radebe	Security Officer		View
Alexander Kent	In-house Senior Legal Counsel	Slough, England, United Kingdom	Email
Lilia Whyla	Sales Attendant Di Cell Medica	Jakarta, Indonesia	View
Oumar Diouf	Senior Director of Cmc at Marker	Greater Houston, United States	Email